SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000094
Filing Date
2024-02-28
Accepted
2024-02-28 17:29:13
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6189
  Complete submission text file 0001610717-24-000094.txt   7657
Mailing Address C/O POINT BIOPHARMA GLOBAL INC. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 24697285

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)